18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
To access this article, please choose from the options below
PII: S0197-4580(07)00497-6
doi:10.1016/j.neurobiolaging.2007.12.021
© 2008 Elsevier Inc. All rights reserved.
